Breast cancer precursors revisited: molecular features and progression pathways

MA Lopez‐Garcia, FC Geyer, M Lacroix‐Triki… - …, 2010 - Wiley Online Library
Lopez‐Garcia MA, Geyer FC, Lacroix‐Triki M, Marchió C & Reis‐Filho JS (2010)
Histopathology 57, 171–192 Breast cancer precursors revisited: molecular features and …

[HTML][HTML] Lobular breast cancer: a review

N Wilson, A Ironside, A Diana, O Oikonomidou - Frontiers in oncology, 2021 - frontiersin.org
Invasive lobular carcinoma accounts for 5%–15% of all invasive breast cancers, with a
marked increase in incidence rates over the past two decades. Distinctive biological …

Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry

DJ Dabbs, SJ Schnitt, FC Geyer, B Weigelt… - The American journal …, 2013 - journals.lww.com
Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and
atypical lobular hyperplasia. These lesions have been shown to constitute both risk …

Calcification in breast lesions: pathologists' perspective

GM Tse, PH Tan, ALM Pang, APY Tang… - Journal of clinical …, 2008 - jcp.bmj.com
Evaluation of calcification in breast lesions is a major assessment criterion for breast
mammography. The morphology and distribution of the calcification are related to the …

Atypical lobular hyperplasia and classic lobular carcinoma in situ can be safely managed without surgical excision

A Laws, F Katlin, F Nakhlis, SA Chikarmane… - Annals of Surgical …, 2022 - Springer
Background Based on modern series demonstrating low upgrade rates for pure lobular
neoplasia (LN) diagnosed on core needle biopsy (CNB), our institution no longer …

[HTML][HTML] Lobular neoplasia: morphology, biological potential and management in core biopsies

FP O'malley - Modern pathology, 2010 - Elsevier
Lobular neoplasia has been traditionally recognized as a marker of increased risk for
subsequent breast carcinoma development; however, molecular studies suggest that it also …

Avoiding “false positive” and “false negative” immunohistochemical results in breast pathology

Z Li, DJ Dabbs - Pathobiology, 2022 - karger.com
Immunohistochemistry (IHC) plays an important role in the evaluation of breast pathology
specimens to provide both diagnostic and prognostic/therapeutic information. Although most …

Breast disease: benign and malignant

ALW Meisner, MH Fekrazad, ME Royce - Medical Clinics of North America, 2008 - Elsevier
Breast diseases, both benign and malignant, are common. Typically, young women present
with more benign pathologies; however, breast malignancies can occur in young women …

Large volume “mammotome” biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast

PJ Carder, T Khan, P Burrows, N Sharma - Journal of clinical pathology, 2008 - jcp.bmj.com
Background: There is currently debate as to whether all papillary lesions diagnosed on
breast needle core biopsy (BNCB) require surgical excision. The development of large …

Screen‐detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis

PJ Carder, A Shaaban, Y Alizadeh… - …, 2010 - Wiley Online Library
Carder PJ, Shaaban A, Alizadeh Y, Kumarasuwamy V, Liston JC & Sharma N (2010)
Histopathology 57, 472–478 Screen‐detected pleomorphic lobular carcinoma in situ …